isomethyleugenol has been researched along with Prostatic Neoplasms in 153 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 6 (3.92) | 18.7374 |
1990's | 12 (7.84) | 18.2507 |
2000's | 47 (30.72) | 29.6817 |
2010's | 65 (42.48) | 24.3611 |
2020's | 23 (15.03) | 2.80 |
Authors | Studies |
---|---|
Cao, Q; Chen, K; Dong, X; Fazli, L; Li, C; Li, F; Li, Y; Wang, L; Wang, R; Wu, L; Yi, Y; Zhao, D; Zhao, W | 1 |
Bai, Y; Dai, JY; Li, Y; Luo, H; Song, YP; Tang, XL; Xian, P | 1 |
Cheng, S; Ding, L; Jiang, M; Li, G; Lin, Y; Lu, H; Lu, Z; Luo, W; Neuhaus, J; Ren, L; Shen, D; Su, W; Wang, H; Wang, R; Xia, L; Xie, H; Xue, D; Yu, C; Zheng, Q; Zhou, Z | 1 |
Bao, J; Gu, X; Li, X; Liu, Y; Song, S; Wang, J; Wang, Z; Xu, B; Yang, Q; Yu, G; Zhan, M | 1 |
Abramovic, I; Bulimbašić, S; Kuliš, T; Pezelj, I; Sincic, N; Škara, L; Tomas, D; Ulamec, M; Vodopić, T; Vrhovec, B; Vrtarić, A | 1 |
Bravou, V; Grypari, IM; Megalooikonomou, V; Melachrinou, M; Papastergiou, T; Pappa, I; Tzelepi, V; Zolota, V | 1 |
Cao, M; Ding, D; Gao, J; Liu, G | 1 |
Feng, N; Feng, Y; Gu, C; Hu, L; Liu, F; Lu, YJ; Sheng, J; Wang, K; Wang, Y; Xu, B; Xu, X; Yang, D; Zhang, Y; Zhu, S | 1 |
Nouruzi, S; Tabrizian, N; Zoubeidi, A | 1 |
Gan, Y; Hou, W; Li, C; Peng, D; Wang, B; Wang, L; Xiong, W; Yuan, P; Zhou, L | 1 |
Dobreva, G; Duman, MB; Mathes, A; Neumann, A; Schmidt, T | 1 |
Gu, R; Janknecht, R; Kim, TD; Oh, S; Shin, S; Song, H; Sui, Y | 1 |
Chen, T; Li, T; Sun, L; Yu, J | 1 |
Cao, Y; Cui, L; Ding, T; He, X; Lu, H; Shi, Q; Tian, Z; Xia, W; Xu, R; Xue, D; Yang, H; Zhou, Y | 1 |
Chu, JW; Im, H; Kim, H; Lee, JM; Park, IG; Park, SC; Song, H | 1 |
Dong, BJ; Gao, WQ; Wang, F; Wang, N; Wang, Y; Zhu, Y | 1 |
Deng, Y; Lin, H; Liu, Y; Luo, L; Wang, J; Xiang, Q; Zhao, Z; Zhou, M; Zhu, Z | 1 |
Gong, Y; He, S; Huang, C; Ji, G; Li, X; Song, G; Zhou, L | 1 |
Jeong, CW; Kim, BC; Kim, HH; Ku, JH; Kwak, C; Lee, KH | 1 |
Gu, B; Lan, T; Li, H; Li, S; Ma, P; Yin, L; Zhang, H | 1 |
Battaglia, S; Cortes Gomez, E; Gillard, B; Karasik, E; Koya, RC; Lugade, A; Matsuzaki, J; Odunsi, K; Singh, PK; Thorne, JL; Tsuji, T; Want, MY | 1 |
Gao, X; He, YH; Hu, GS; Huang, HH; Huang, MF; Li, WJ; Lin, YA; Liu, W; Peng, BL; Ran, T; Xie, BL; Yang, JJ; Ye, F; Zhu, HH | 1 |
Shao, C; Sun, H; Zhao, Y; Zheng, J | 1 |
Cheng, X; Ma, Z; Pan, J; Shangguan, X; Wang, Q; Xin, Z; Xue, W; Yue, T; Zhang, W | 1 |
Li, M; Liu, J; Luo, J; Wang, Y | 1 |
Bakavicius, A; Daniunaite, K; Dubikaityte, M; Gibas, P; Jankevicius, F; Jarmalaite, S; Rimantas Lazutka, J; Ulys, A | 1 |
Fan, L; Filipp, FV; Qi, J; Sahgal, N; Wilson, S | 1 |
Bernard-Gallon, D; Bignon, YJ; Daures, M; Guy, L; Idrissou, M; Jemia, AB; Judes, G; Penault-Llorca, F; Rifaï, K | 1 |
Casadio, V; Costantini, M; Gunelli, R; Gurioli, G; Martignano, F; Salvi, S | 1 |
Darwish, HA; Diab, I; Helmy, MW; Motawi, TK; Noureldin, MH | 1 |
Chun, YS; Kang, J; Lee, GY; Lee, M; Park, JW; Shin, HW; Shin, SH | 1 |
Adhami, VM; Ateeq, B; Choudhry, H; Hamid, A; Khan, MI; Khan, Q; Mukhtar, H; Rath, S; Siddiqui, IA; Zamzami, MA | 1 |
Cao, Q; Fong, KW; Kim, J; Lee, Y; Licht, JD; Lu, X; Song, B; Yu, J; Zhao, JC | 1 |
Han, L; Hu, Z; Lou, H; Niu, H; Qian, L; Tian, K; Wang, L; Wang, Y; Yuan, H; Zhu, M | 1 |
Dubrovska, A; Gorodetska, I; Kozeretska, I; Lukiyanchuk, V; Peitzsch, C | 1 |
Deb, M; Kar, S; Parbin, S; Patra, SK; Pradhan, N; Sengupta, D | 1 |
Bavafaye-Haghighi, E; Besenbacher, S; Borre, M; Hoyer, S; Kristensen, H; Mouritzen, P; Orntoft, TF; Rasmussen, AK; Sorensen, KD; Strand, SH | 1 |
Khor, TO; Kong, AN; Shu, L; Su, ZY; Zhang, C | 1 |
Alves, G; Arnaud, P; Baron, S; Caira, F; De Boussac, H; Dufour, J; Lobaccaro, JM; Pommier, AJ; Trousson, A; Val, P; Viennois, E; Volle, DH | 1 |
Huang, H; Tindall, DJ; van der Steen, T | 1 |
Alptekin, A; Cinar, B; Kuser-Abali, G | 1 |
Baker, MR; Banerjee, T; Barish, GD; Chakravarti, D; Kim, JY; Luo, Q; Parker, JB; Radhakrishnan, I; Vinckevicius, A; Wei, JJ | 1 |
Guo, B; Padi, SK; Tindall, DJ; Zhang, Q | 1 |
Cai, T; Guo, X; Hou, J; Liu, CC; Liu, P; Niu, L; Shu, Q; Yang, F | 1 |
Aburatani, H; Fujimura, T; Homma, Y; Inoue, S; Suzuki, T; Takahashi, S; Takayama, K; Tsutsumi, S; Urano, T | 1 |
Huang, JT; Li, C; Nabi, G; Wrobel, K; Zang, T | 1 |
Chen, J; Fu, X; Fu, Y; Liao, K; Qian, X; Ren, L; Xiao, J | 1 |
Chen, J; Cheong, A; Ho, SM; Hu, WY; Lam, HM; Leung, YK; Medvedovic, M; Prins, GS; Shi, GB; Zhang, X; Zhu, X | 1 |
Bondarenko, SP; Cai, X; Fiandalo, MV; Frasinyuk, MS; Liu, C; Mohler, JL; Mrug, GP; Sviripa, VM; Watt, DS; Zhang, W | 1 |
Abbas, A; Al-Mulla, F; Georgel, PT; Hall, JA; Ho, E; Hsu, A; Patterson, WL | 1 |
Deng, QK; Fu, XL; Li, WP; Lin, YL; Ma, JG; Wang, YH | 1 |
Hou, L; Li, M; Li, Q; Yu, Y; Zhang, D | 1 |
Bedford, MT; Dengjel, J; Eberlin, A; Einsle, O; Espejo, A; Flaig, R; Forne, I; Gerhardt, S; Imhof, A; Jung, M; McMillan, J; Metzger, E; Metzger, P; Perner, S; Petroll, K; Schleicher, M; Schott, AK; Schüle, KM; Schüle, R; Urban, S; von Maessenhausen, A; Willmann, D; Wohlwend, D | 1 |
Cang, S; Chiao, JW; Liu, D; Ma, Y; Xu, X | 1 |
Deng, QK; Lei, YG; Li, WP; Lin, YL; Ma, JG | 1 |
Arnold, RD; Cummings, BS; Glenn, TC; Kolli, RT; Moore, M; Scholpa, NE | 1 |
Bao, HB; Cui, RJ; Fan, JL; Li, D; Lin, P; Pan, YJ; Si, SH; Sun, H; Sun, WJ; Wen, SM; Yu, XG; Zheng, XL | 1 |
Cackowski, FC; Decker, AM; Franceschi, RT; Jung, Y; Lee, E; Li, Y; Pienta, KJ; Taichman, RS; Wang, J; Yumoto, K | 1 |
Qiu, Z; Wang, J; Zheng, G; Zhou, B | 1 |
Chen, R; Dong, L; Huang, Y; Li, B; Liu, J; Pang, J; Wang, D; Yang, J; Yang, YW; Zhang, H | 1 |
Anestopoulos, I; Chlichlia, K; Franco, R; Kroll, DJ; Panayiotidis, MI; Pappa, A; Sfakianos, AP | 1 |
Chakravarti, D; Chen, JR; Chen, P; Deng, P; DePinho, RA; Dey, P; Lan, Z; Li, J; Liang, X; Liao, W; Lu, X; Navone, NM; Shah, S; Shang, X; Spring, DJ; Tang, M; Troncoso, P; Wang, G; Wang, YA; Zhang, J; Zhao, D | 1 |
Datar, RH; Groshen, S; Imam, SA; Jones, LW; Kaur, P; Naritoku, WY; Saha, B; Tsao-Wei, D | 1 |
Ateeq, B; Brenner, JC; Cao, Q; Cao, X; Chinnaiyan, AM; Han, B; Jing, X; Kim, JH; Kumar-Sinha, C; Laxman, B; Lonigro, RJ; Maher, CA; Mani, RS; Palanisamy, N; Ramnarayanan, K; Shankar, S; Tan, P; Varambally, S; Wang, X; Yu, J | 1 |
Gopisetty, G; Gordian, E; Hader, C; Navarro, L; Ramachandran, K; Reis, IM; Schulz, WA; Singal, R | 1 |
Akslen, LA; Goldfinger, N; Halvorsen, OJ; Haukaas, SA; Jonassen, I; Kalland, KH; Ke, XS; Li, WC; Lin, B; Oyan, AM; Petersen, K; Qu, Y; Rostad, K; Rotter, V | 1 |
Chia, D; Goodglick, L; Horvath, S; Kurdistani, SK; Mah, V; McBrian, MA; Seligson, DB; Tze, S; Wang, Q; Yu, H | 1 |
Chiu, CY; Huang, DY; Huang, YS; Kao, CF; Lin, CT; Lu, TY; Wu, HC | 1 |
Astacio, T; Baden, J; Canning, S; Curtin, K; Green, G; Guinto, W; Jones, J; Leibovich, BC; Markiewicz, J; Nelson, JB; Painter, J; Quijano, J; Vargo, J; Wang, Y; Wuxiong, C | 1 |
Niwa, T; Shimazu, T; Takeshima, H; Ushijima, T; Yamashita, S | 1 |
Alhonen, L; Hyvönen, MT; Keinänen, TA; Khomutov, AR; Nayvelt, I; Pandya, I; Patel, R; Thomas, T; Thomas, TJ; Vepsäläinen, J | 1 |
Clark, SJ; Coolen, MW; Cowley, M; Kaplan, W; Kassir, Z; Lacaze, P; Moreno, CS; Robinson, MD; Song, JZ; Speed, TP; Statham, AL; Stirzaker, C; Varma, V; Young, AN | 1 |
Wang, YC; Xia, SJ | 1 |
Cheng, W; Du, X; Huang, Q; Huang, W; Jiang, L; Lai, D; Liu, T; Liu, Z; Xu, F; Zhao, Y | 1 |
Beisenherz-Huss, C; Buettner, R; Friedrichs, N; Greschik, H; Günther, T; Hoffmeyer, K; Imhof, A; Ji, S; Kahl, P; Kirfel, J; Kunowska, N; Metzger, E; Müller, JM; Patel, D; Schüle, R | 1 |
Albertini, V; Cangemi, R; Carbone, GM; Catapano, CV; Chiorino, G; Kunderfranco, P; Malek, A; Mello-Grand, M; Mensah, A; Pellini, S | 1 |
Gil, J; Li, S; Mujtaba, S; Muñoz-Cabello, AM; Raguz, S; Walsh, MJ; Yap, KL; Zeng, L; Zhou, MM | 1 |
Yano, K | 1 |
Dalay, N; Darendeliler, E; Deligezer, U; Dizdar, Y; Holdenrieder, S; Kovancilar, M; Yaman, F | 1 |
Agirre, X; Calvo, A; Catena, R; Fernandez-Montero, JM; Guillen-Grima, F; Prior, C; Robles, JE; Rosell, D | 1 |
Ye, D; Zhu, Y | 1 |
Armstrong, K; Gaughan, L; McCracken, SR; McEwan, IJ; Pestell, RG; Robson, CN; Shaheen, F; Stockley, J; Treumann, A; Wang, C; Wang, N; Watt, K | 1 |
Chen, CH; Chen, CS; Chen, MC; Chou, CC; Chu, PC; Huang, PH; Kulp, SK; Teng, CM; Wang, D; Wang, Q | 1 |
Cabarcas, SM; Crea, F; Danesi, R; Farrar, WL; Hurt, EM; Marquez, VE; Mathews, LA; Sun, L | 1 |
Byun, J; Creighton, CJ; Fischer, SM; Michailidis, G; Nalluri, S; Palapattu, GS; Pennathur, S; Putluri, N; Putluri, V; Sana, TR; Shojaie, A; Sreekumar, A; Vareed, SK; Vasu, VT; Vivekanandan-Giri, A | 1 |
Haendler, B; Stratmann, A | 1 |
Andreu-Vieyra, C; Berman, BP; Coetzee, GA; Frenkel, B; Jia, L; Jones, PA; Lai, J | 1 |
Balk, SP; Brown, M; Cai, C; Chen, S; Coleman, I; Fang, Z; He, HH; Liu, XS; Nelson, PS; Wang, H | 1 |
Ames, RS; Li, H; Xie, W | 1 |
Cheng, L; Teng, XD; Zhou, J | 1 |
Bastian, PJ; Ellinger, J; Gütgemann, I; Heukamp, LC; Hofstädter, F; Kahl, P; Müller, SC; Rogenhofer, S; von der Gathen, J; von Ruecker, A; Walter, B | 1 |
Jääskeläinen, T; Kim, J; Makkonen, H; Palvimo, JJ; Roeder, RG; Visakorpi, T | 1 |
Buettner, R; Forne, I; Imhof, A; Jandausch, A; Janzer, A; Jung, M; Kirfel, J; Lim, S; Metzger, E; Schüle, R; Waldmann, H; Wetzel, S; Wilk, W; Willmann, D | 1 |
Heber, D; Henning, SM; Wang, P | 1 |
Bethel, C; De Marzo, AM; Gurel, B; Hicks, J; Iwata, T; Pellakuru, LG; Schultz, D; Yegnasubramanian, S | 1 |
Ezponda, T; Kelleher, NL; Licht, JD; Martinez-Garcia, E; Min, DJ; Neri, A; Popovic, R; Shah, MY; Will, C; Yu, J; Zheng, Y | 1 |
Lehner, B; Schuster-Böckler, B | 1 |
Ghoshal, K; Jacob, ST; Majumder, S | 1 |
Kitamura, T; Tomita, K | 1 |
Bellarosa, C; Dekleva, V; Diana, F; Giancotti, V; Manfioletti, G; Rustighi, A; Sgarra, R; Toller, M | 1 |
Chai, HB; Chávez, D; Cordell, GA; Díaz, F; Fairchild, CR; Farnsworth, NR; Kardono, LB; Kinghorn, AD; Lee, D; Mi, Q; Pezzuto, JM; Riswan, S; Tan, GT; Wild, R | 1 |
Gonzalgo, ML; Lee, SM; Nelson, WG; Pavlovich, CP | 1 |
Epstein, JI; Goodman, SN; Harden, SV; Partin, AA; Sanderson, H; Sidransky, D; Walsh, PC | 1 |
Klein, EA | 1 |
Epstein, JI; Sidransky, D; Tokumaru, Y; Zhou, M | 1 |
Fujimura, T; Fujita, M; Horie-Inoue, K; Inoue, S; Kitamura, T; Kumagai, J; Ouchi, Y; Sasano, H; Suzuki, T; Takahashi, S; Urano, T | 1 |
Jänne, OA; Kang, Z; Palvimo, JJ | 1 |
Blair, SL; Crocitto, LE; Kawachi, MH; Korns, D; Kretzner, L; Ramin, SA; Shevchuk, T; Smith, SS; Wilson, TG | 1 |
Cardile, V; Lombardo, L; Spatafora, C; Tringali, C | 1 |
Marx, J | 1 |
Kato, T | 1 |
Marte, B | 1 |
Grunstein, M; Horvath, S; Kurdistani, SK; Seligson, DB; Shi, T; Tze, S; Yu, H | 1 |
Bergh, A; Bono, A; Foster, C; Gospadarowicz, M; Isaacs, WB; Rubin, M; Schalken, JA; Schröder, F; Tribukait, B; Tsukamotot, T; Wiklund, P | 1 |
Buettner, R; Günther, T; Metzger, E; Müller, JM; Peters, AH; Schneider, R; Schüle, R; Wissmann, M; Yin, N | 1 |
Abate-Shen, C; Chuikov, S; Farnham, P; Karachentsev, D; Kirmizis, A; Kuzmichev, A; Margueron, R; Nishioka, K; Preissner, TS; Reinberg, D; Sarma, K; Steward, R; Vaquero, A | 1 |
Ito, H; Komiya, A | 1 |
Carvalho, AL; Henrique, R; Hoque, MO; Jerónimo, C; Lopes, C; Oliveira, J; Pais, I; Ribeiro, FR; Sidransky, D; Teixeira, MR | 1 |
Kuo, MH; Lee, DY; Northrop, JP; Stallcup, MR | 1 |
Ford, OH; Liu, Y; Majumder, S; Mohler, JL; Whang, YE | 1 |
Metzger, E; Schüle, R; Wissmann, M | 1 |
Coetzee, GA; Gentzschein, E; Jia, L; Jones, PA; Khalid, O; Liang, G; Pinski, JK; Shen, HC; Stanczyk, FZ; Wang, Q; Wantroba, M | 1 |
Bartsch, G; Bellezza, I; Cavarretta, IT; Culig, Z; Doppler, W; Hobisch, A; Minelli, A; Nemes, C; Neuwirt, H; Offner, F; Puhr, M; Steiner, H | 1 |
Albert, PS; Chuaqui, RF; Emmert-Buck, MR; Erickson, HS; Gillespie, JW; Hanson, JC; Libutti, SK; Linehan, WM; Merino, MJ; Pinto, PA; Richardson, AM; Rodriguez-Canales, J; Tangrea, MA; Wallis, BS; Woodson, KG | 1 |
Allgood, JC; Dillehay, DL; Merrill, AH; Moody, SJ; Morales, PR; Pallas, DC; Pruett, S; Symolon, H | 1 |
Pulukuri, SM; Rao, JS | 1 |
Blaue, C; Eilers, T; Hagemann, J; Jonas, U; Lichtinghagen, R; Machtens, S; Serth, J; Tezval, H | 1 |
Igawa, M; Moriyama-Gonda, N; Satoh, K; Shiina, H; Terashima, M | 1 |
Chen, CD; Han, G; Lin, H; Xiang, Y; Xu, L; Zhu, Z | 1 |
Chen, AP; Chen, CD; Han, G; Lin, H; Ma, Y; Peng, Z; Xiang, Y; Xu, B; Ye, X; Yu, Y; Zhu, Z | 1 |
Dahiya, R; Hirata, H; Igawa, M; Kawamoto, K; Kikuno, N; Majid, S; Shiina, H; Tanaka, Y; Urakami, S | 1 |
Erb, N; Heller-Schöch, G; Lorenz, H; Müller, J; Schöch, G; Winkler, K | 1 |
Benson, MC; Coffey, DS | 2 |
Baylin, SB; Chopra, H; Davidson, NE; Graff, JR; Herman, JG; Isaacs, WB; Jarrard, DF; Lapidus, RG; Pitha, PM; Xu, R | 1 |
Bova, GS; Brooks, JD; Bussemakers, MJ; Ewing, CM; Isaacs, WB; Morton, RA | 3 |
Bova, GS; Brooks, JD; Campbell, PA; Epstein, JI; Hsieh, WS; Isaacs, WB; Lee, WH; Morton, RA; Nelson, WG | 1 |
Blount, LV; Cooke, DB | 1 |
Bova, GS; Isaacs, WB; Jarrard, DF | 1 |
Baylin, SB; Herman, JG; Jen, J; Merlo, A | 1 |
Bookstein, R; Bova, GS; Isaacs, WB; Levy, A; MacGrogan, D | 2 |
Baylin, SB; Bova, GS; Isaacs, WB; Morton, RA; Wales, MM; Watkins, JJ | 1 |
Bova, GS; Brooks, JD; Jarrard, DF; Lee, WH; Magnuson, SR; Nelson, JB; Nelson, WG; Nguyen, SH; Opgenorth, TJ | 1 |
Ho, SM; LaSpina, M; Lau, KM; Long, J | 1 |
Carroll, P; Dahiya, R; Li, LC; Nakajima, K; Oh, BR; Ribeiro Filho, LA; Zhao, H | 1 |
Asgari, K; Bova, GS; Brooks, JD; De Marzo, AM; DeWeese, TL; Freije, D; Gage, WR; Isaacs, WB; Lee, BH; Lee, WH; Lin, X; Nelson, WG; Tascilar, M; van Rees, B; Veeraswamy, R; Vles, WJ | 1 |
Goessl, C; Heicappell, R; Krause, H; Miller, K; Müller, M; Schostak, M; Straub, B | 1 |
Asberry, BE; Coleman, RE; Fair, WR; Primeau, JL; Straatmann, MG; Ter-Pogossian, MM; Welch, MJ | 1 |
Bedford, MT; van Helden, PD | 1 |
Pillinger, DJ; Wilkinson, R | 1 |
17 review(s) available for isomethyleugenol and Prostatic Neoplasms
Article | Year |
---|---|
Beyond Expression: Role of Phosphorylated Residues of EZH2 in Lineage Plasticity in Prostate Cancer.
Topics: Carcinogenesis; Enhancer of Zeste Homolog 2 Protein; Gene Expression Regulation, Neoplastic; Humans; Male; Methylation; Polycomb Repressive Complex 2; Prostatic Neoplasms | 2023 |
GSTP1 methylation in cancer: a liquid biopsy biomarker?
Topics: Biomarkers, Tumor; Glutathione S-Transferase pi; Humans; Liquid Biopsy; Male; Methylation; Prostatic Neoplasms | 2018 |
Posttranslational modification of the androgen receptor in prostate cancer.
Topics: Acetylation; Humans; Male; Methylation; Phosphoric Monoester Hydrolases; Phosphorylation; Prostatic Neoplasms; Protein Processing, Post-Translational; Protein Structure, Tertiary; Receptors, Androgen; Sumoylation; Ubiquitination | 2013 |
Characterization of the roles of suppressor of cytokine signaling-3 in prostate cancer development and progression.
Topics: Androgens; Apoptosis; Disease Progression; Humans; Interleukin-6; Male; Methylation; Prostatic Neoplasms; Signal Transduction; Suppressor of Cytokine Signaling Proteins | 2015 |
[An update of biomarkers in prostate cancer tissue].
Topics: Biomarkers, Tumor; Early Diagnosis; Humans; Male; Methylation; Prostatic Neoplasms | 2009 |
[The mechanism and predictive factors of hormone-independent recurrence of prostate cancer].
Topics: Androgens; Apoptosis; Cadherins; Caveolin 1; Caveolins; Cell Adhesion; Growth Substances; Humans; Male; Methylation; Mutation; Neoplasm Recurrence, Local; Promoter Regions, Genetic; Prostatic Neoplasms; Receptors, Androgen; Trinucleotide Repeats | 2002 |
Selenium: epidemiology and basic science.
Topics: Animals; Antioxidants; Humans; Male; Methylation; Molecular Epidemiology; Prostatic Neoplasms; Selenium | 2004 |
Molecular prostate cancer pathology: current issues and achievements.
Topics: Antigens, Neoplasm; Biomarkers, Tumor; DNA-Binding Proteins; DNA, Mitochondrial; E2F3 Transcription Factor; Enhancer of Zeste Homolog 2 Protein; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Genetic Markers; Genome, Human; Glutathione S-Transferase pi; Humans; Male; Methylation; Microsatellite Repeats; Mutation; Polycomb Repressive Complex 2; Prostate-Specific Antigen; Prostatic Neoplasms; Racemases and Epimerases; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Serine Endopeptidases; Telomerase; Transcription Factors; Tumor Suppressor Proteins | 2005 |
Steps toward understanding the inheritance of repressive methyl-lysine marks in histones.
Topics: Amino Acid Sequence; Animals; Drosophila; Drosophila Proteins; Epigenesis, Genetic; Histone Methyltransferases; Histone-Lysine N-Methyltransferase; Histones; Humans; Lysine; Male; Methylation; Mice; Nuclear Proteins; Polycomb Repressive Complex 2; Prostatic Neoplasms; Protein Methyltransferases; Repressor Proteins; Sequence Homology, Amino Acid | 2004 |
[Androgen receptor].
Topics: Androgen-Insensitivity Syndrome; Androgens; Biomarkers; Diagnostic Techniques, Endocrine; Humans; Male; Methylation; Polymerase Chain Reaction; Polymorphism, Genetic; Prostatic Neoplasms; Receptors, Androgen; Specimen Handling; Trinucleotide Repeats | 2005 |
Histone demethylation and androgen-dependent transcription.
Topics: Androgens; Histone Demethylases; Histones; Humans; Male; Methylation; Oxidoreductases, N-Demethylating; Prostatic Neoplasms; Transcription, Genetic | 2006 |
New concepts and controversies concerning prostate cancer.
Topics: Acid Phosphatase; DNA, Neoplasm; Estramustine; Flow Cytometry; Gonadotropin-Releasing Hormone; Humans; Immunotherapy; Male; Methylation; Oncogenes; Prostatic Neoplasms | 1984 |
Genetic alterations in prostate cancer.
Topics: alpha Catenin; Cadherins; Chromosome Mapping; Chromosomes, Human, Pair 16; Cytoskeletal Proteins; DNA, Neoplasm; Gene Deletion; Genes, p53; Genes, ras; Genes, Retinoblastoma; Genes, Tumor Suppressor; Heterozygote; Humans; Male; Methylation; Prostatic Neoplasms | 1994 |
Molecular biology of prostate cancer progression.
Topics: Cadherins; Chromosome Deletion; DNA; Genes, Retinoblastoma; Humans; Male; Methylation; Oncogenes; Prostatic Neoplasms | 1995 |
Molecular biology of prostate cancer.
Topics: alpha Catenin; Cadherins; Cell Line, Transformed; Cytoskeletal Proteins; DNA, Neoplasm; Gene Expression; Genes, p53; Genes, ras; Genes, Retinoblastoma; Heterozygote; Humans; Male; Methylation; Oncogenes; Prostatic Neoplasms | 1994 |
DNA methylation, molecular genetic, and linkage studies in prostate cancer.
Topics: Chromosome Deletion; DNA; Genes, Tumor Suppressor; Genetic Linkage; Humans; Male; Methylation; Prostatic Neoplasms | 1996 |
Tumour-suppressor genes in prostatic oncogenesis: a positional approach.
Topics: Amino Acid Sequence; Blotting, Southern; Chromosome Mapping; Chromosomes, Human, Pair 6; Gene Deletion; Gene Expression Regulation, Neoplastic; Genes, Tumor Suppressor; Genetic Markers; Humans; Male; Methylation; Molecular Sequence Data; Mutation; Oncogenes; Prostatic Neoplasms | 1997 |
1 trial(s) available for isomethyleugenol and Prostatic Neoplasms
Article | Year |
---|---|
Multicenter evaluation of an investigational prostate cancer methylation assay.
Topics: Adult; Aged; Biological Assay; Digital Rectal Examination; Humans; Male; Methylation; Middle Aged; Polymerase Chain Reaction; Prospective Studies; Prostatic Neoplasms | 2009 |
135 other study(ies) available for isomethyleugenol and Prostatic Neoplasms
Article | Year |
---|---|
Methylation-dependent and -independent roles of EZH2 synergize in CDCA8 activation in prostate cancer.
Topics: Cell Cycle Proteins; Cell Line, Tumor; Enhancer of Zeste Homolog 2 Protein; Gene Expression Regulation, Neoplastic; Humans; Male; Methylation; Prostatic Neoplasms | 2022 |
Comprehensive Landscape of HOXA2, HOXA9, and HOXA10 as Potential Biomarkers for Predicting Progression and Prognosis in Prostate Cancer.
Topics: Biomarkers, Tumor; Genes, Homeobox; Homeobox A10 Proteins; Homeodomain Proteins; Humans; Male; Methylation; Prognosis; Prostatic Neoplasms | 2022 |
circPDE5A regulates prostate cancer metastasis via controlling WTAP-dependent N6-methyladenisine methylation of EIF3C mRNA.
Topics: Cell Cycle Proteins; Cell Line, Tumor; Eukaryotic Initiation Factor-3; Gene Expression Regulation, Neoplastic; Humans; Male; Methylation; Prostatic Neoplasms; RNA Splicing Factors; RNA, Circular; RNA, Messenger | 2022 |
Comprehensive Analysis of m5C Methylation Regulatory Genes and Tumor Microenvironment in Prostate Cancer.
Topics: Cytidine; Genes, Regulator; Humans; Male; Methylation; Prostatic Neoplasms; RNA; Tumor Microenvironment | 2022 |
Methylation pattern of caveolin-1 in prostate cancer as potential cfDNA biomarker.
Topics: Biomarkers; Caveolin 1; Cell-Free Nucleic Acids; Humans; Male; Methylation; Prostatic Hyperplasia; Prostatic Neoplasms | 2023 |
Elucidating the role of PRMTs in prostate cancer using open access databases and a patient cohort dataset.
Topics: Access to Information; Arginine; Cell Nucleus; Humans; Jumonji Domain-Containing Histone Demethylases; Male; Methylation; Nuclear Proteins; Prostatic Neoplasms; Protein-Arginine N-Methyltransferases | 2023 |
Unveiling the m6A Methylation Regulator Links between Prostate Cancer and Periodontitis by Transcriptomic Analysis.
Topics: Fragile X Mental Retardation Protein; Humans; Male; Methylation; Periodontitis; Prostatic Neoplasms; RNA; Transcriptome; Tumor Suppressor Protein p53; Ubiquitins | 2022 |
Hsa_circ_0094606 promotes malignant progression of prostate cancer by inducing M2 polarization of macrophages through PRMT1-mediated arginine methylation of ILF3.
Topics: Arginine; Cell Line, Tumor; Cell Proliferation; Gene Expression Regulation, Neoplastic; Humans; Interleukin-8; Macrophages; Male; Methylation; Methyltransferases; MicroRNAs; Prostatic Neoplasms; Protein-Arginine N-Methyltransferases; Repressor Proteins; RNA; RNA, Circular | 2023 |
The m
Topics: Adenocarcinoma; Clinical Relevance; Humans; Male; Methylation; MicroRNAs; Neoplasm Recurrence, Local; Prostate; Prostatic Neoplasms; RNA, Long Noncoding | 2023 |
S-adenosylmethionine treatment affects histone methylation in prostate cancer cells.
Topics: DNA Methylation; Histones; Humans; Male; Methylation; Prostatic Neoplasms; Protein Processing, Post-Translational; S-Adenosylmethionine | 2024 |
SET7/9-mediated methylation affects oncogenic functions of histone demethylase JMJD2A.
Topics: Carcinogenesis; Cell Transformation, Neoplastic; Histone Demethylases; Humans; Jumonji Domain-Containing Histone Demethylases; Lysine; Male; Matrix Metalloproteinase 1; Methylation; Prostatic Neoplasms | 2023 |
LncRNA IUR downregulates ZEB1 by upregulating miR-200 to inhibit prostate carcinoma.
Topics: Adult; Aged; Cell Line, Tumor; Cell Movement; Down-Regulation; Gene Expression Regulation, Neoplastic; Humans; Male; Methylation; MicroRNAs; Middle Aged; Neoplasm Invasiveness; Prostatic Neoplasms; RNA, Long Noncoding; Transfection; Up-Regulation; Zinc Finger E-box-Binding Homeobox 1 | 2019 |
LncRNA MEG3 inhibits the progression of prostate cancer by facilitating H3K27 trimethylation of EN2 through binding to EZH2.
Topics: Animals; Cell Line, Tumor; Cell Movement; Cell Proliferation; Chromatin Immunoprecipitation; Disease Progression; Down-Regulation; Enhancer of Zeste Homolog 2 Protein; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Histones; Homeodomain Proteins; Humans; Male; Methylation; Mice; Mice, Inbred BALB C; Mice, Nude; Nerve Tissue Proteins; Prostatic Neoplasms; RNA, Long Noncoding; Up-Regulation; Xenograft Model Antitumor Assays | 2020 |
Isoform-Specific Lysine Methylation of RORα2 by SETD7 Is Required for Association of the TIP60 Coactivator Complex in Prostate Cancer Progression.
Topics: Animals; Cell Proliferation; Chromatin Immunoprecipitation; Chromatography, Liquid; Disease Progression; Gene Expression Regulation, Neoplastic; Histone-Lysine N-Methyltransferase; Humans; Lysine; Lysine Acetyltransferase 5; Male; Methylation; Mice; Mice, Nude; Nuclear Receptor Subfamily 1, Group F, Member 1; Oncogenes; PC-3 Cells; Prostatic Neoplasms; Protein Binding; Protein Domains; Protein Isoforms; Tandem Mass Spectrometry; Trans-Activators | 2020 |
Wnt/β-catenin signaling contributes to prostate cancer heterogeneity through reciprocal suppression of H3K27 trimethylation.
Topics: Antineoplastic Agents; Apoptosis; Cell Line; Cell Proliferation; Docetaxel; Dose-Response Relationship, Drug; Humans; Male; Methylation; PC-3 Cells; Prostatic Neoplasms; Structure-Activity Relationship; Wnt Signaling Pathway | 2020 |
The m6A methylation regulator-based signature for predicting the prognosis of prostate cancer.
Topics: Adenosine; Cluster Analysis; Computational Biology; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Male; Methylation; Prognosis; Proportional Hazards Models; Prostatic Neoplasms; RNA, Messenger; ROC Curve; Transcriptome | 2020 |
Comprehensive analysis of m6A regulators prognostic value in prostate cancer.
Topics: AlkB Homolog 5, RNA Demethylase; Gene Expression Regulation, Neoplastic; Heterogeneous-Nuclear Ribonucleoprotein Group A-B; Humans; Male; Methylation; Methyltransferases; Prognosis; Progression-Free Survival; Prostatic Neoplasms; RNA Processing, Post-Transcriptional; RNA-Binding Proteins | 2020 |
MLL5, a histone modifying enzyme, regulates androgen receptor activity in prostate cancer cells by recruiting co-regulators, HCF1 and SET1.
Topics: Cell Line, Tumor; Cell Movement; Cell Proliferation; DNA-Binding Proteins; Gene Expression Regulation, Neoplastic; Histone-Lysine N-Methyltransferase; Histones; Host Cell Factor C1; Humans; Male; Methylation; Promoter Regions, Genetic; Prostatic Neoplasms; Protein Processing, Post-Translational; Receptors, Androgen; Signal Transduction; Transcription Factors | 2020 |
Diagnostic value of DACT-2 methylation in serum of prostate cancer patients.
Topics: Humans; Male; Methylation; Prognosis; Prostatic Hyperplasia; Prostatic Neoplasms; ROC Curve | 2021 |
WHSC1/NSD2 regulates immune infiltration in prostate cancer.
Topics: Animals; CD8-Positive T-Lymphocytes; Cell Line, Tumor; DNA Methylation; Epigenesis, Genetic; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Histone-Lysine N-Methyltransferase; Histones; Humans; Lymphocytes, Tumor-Infiltrating; Male; Methylation; Mice; Mice, Transgenic; Neoplasm Transplantation; Prognosis; Prostatic Neoplasms; Quinoxalines; Repressor Proteins; Sequence Analysis, RNA; Survival Analysis; Tumor Microenvironment | 2021 |
Profiling PRMT methylome reveals roles of hnRNPA1 arginine methylation in RNA splicing and cell growth.
Topics: Alternative Splicing; Amino Acid Sequence; Arginine; Breast Neoplasms; Cell Cycle; Cell Line, Tumor; Colorectal Neoplasms; Enzyme Inhibitors; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; HEK293 Cells; Heterogeneous Nuclear Ribonucleoprotein A1; Humans; Male; Methylation; Prostatic Neoplasms; Protein Binding; Protein Processing, Post-Translational; Protein-Arginine N-Methyltransferases; RNA, Small Interfering; Spliceosomes; Substrate Specificity | 2021 |
Analysis of RNA m
Topics: Biomarkers, Tumor; Humans; Male; Methylation; Prognosis; Prostatic Neoplasms; RNA; Tumor Microenvironment | 2021 |
Immune infiltration phenotypes of prostate adenocarcinoma and their clinical implications.
Topics: Adenocarcinoma; Cohort Studies; Datasets as Topic; Disease Progression; DNA Copy Number Variations; DNA Helicases; DNA Methylation; DNA-Binding Proteins; Gene Expression Profiling; HSC70 Heat-Shock Proteins; Humans; Immunophenotyping; Lymphocytes, Tumor-Infiltrating; Male; Methylation; Microtubule-Associated Proteins; Middle Aged; Mutation; Mutation Rate; Neoplasm Grading; Neoplasm Proteins; Nomograms; Prognosis; Prostatic Neoplasms; Transcriptome; Tumor Microenvironment | 2021 |
Curcumin sensitizes prostate cancer cells to radiation partly via epigenetic activation of miR-143 and miR-143 mediated autophagy inhibition.
Topics: Autophagy; Cell Line, Tumor; Curcumin; Epigenesis, Genetic; Humans; Male; Methylation; MicroRNAs; Prostatic Neoplasms; Radiation Tolerance | 2017 |
Clinical significance of miRNA host gene promoter methylation in prostate cancer.
Topics: Aged; Biomarkers, Tumor; Databases, Nucleic Acid; Disease-Free Survival; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Kaplan-Meier Estimate; Lymphatic Metastasis; Male; Methylation; MicroRNAs; Middle Aged; Prognosis; Promoter Regions, Genetic; Proportional Hazards Models; Prostate; Prostatectomy; Prostatic Hyperplasia; Prostatic Neoplasms | 2017 |
The histone demethylase KDM3A regulates the transcriptional program of the androgen receptor in prostate cancer cells.
Topics: Cell Line, Tumor; Chromatin Immunoprecipitation; Computational Biology; Enzyme Activation; Epigenesis, Genetic; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Gene Regulatory Networks; Genomics; High-Throughput Nucleotide Sequencing; Histones; Humans; Jumonji Domain-Containing Histone Demethylases; Male; Methylation; Molecular Sequence Annotation; Prostatic Neoplasms; Protein Binding; Receptors, Androgen; Signal Transduction; Transcription, Genetic | 2017 |
EZH2 Histone Methyltransferase and JMJD3 Histone Demethylase Implications in Prostate Cancer.
Topics: Adenocarcinoma; Enhancer of Zeste Homolog 2 Protein; Epigenomics; Histones; Humans; Jumonji Domain-Containing Histone Demethylases; Male; Methylation; Promoter Regions, Genetic; Prostatic Neoplasms | 2017 |
Combinatorial strategy of epigenetic and hormonal therapies: A novel promising approach for treating advanced prostate cancer.
Topics: Anticarcinogenic Agents; Azacitidine; beta Catenin; Caspase 3; Cell Proliferation; Cyclin D1; Decitabine; Disease Progression; Epigenesis, Genetic; Estrogen Receptor beta; Hormones; Humans; Hydroxamic Acids; Male; Methylation; Nitriles; Propionates; Prostate; Prostatic Neoplasms; Vascular Endothelial Growth Factor A | 2018 |
Aberrant expression of CITED2 promotes prostate cancer metastasis by activating the nucleolin-AKT pathway.
Topics: Acetylation; Adenocarcinoma; Cell Movement; Epithelial-Mesenchymal Transition; HEK293 Cells; Humans; Male; Methylation; Neoplasm Metastasis; Nucleolin; p300-CBP Transcription Factors; PC-3 Cells; Phosphoproteins; Prostatic Neoplasms; Protein-Arginine N-Methyltransferases; Proto-Oncogene Proteins c-akt; Repressor Proteins; RNA-Binding Proteins; Serine Endopeptidases; Trans-Activators; Transcriptional Regulator ERG | 2018 |
AKT Inhibition Modulates H3K4 Demethylase Levels in PTEN-Null Prostate Cancer.
Topics: Acetylation; Animals; Cell Line, Tumor; Gene Expression Regulation, Neoplastic; Gene Knockout Techniques; Humans; Jumonji Domain-Containing Histone Demethylases; Male; Methylation; Mice; MicroRNAs; Nuclear Proteins; Phosphorylcholine; Prostatic Neoplasms; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Repressor Proteins; Xenograft Model Antitumor Assays | 2019 |
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator.
Topics: Androgens; Animals; Base Sequence; Carcinogenesis; Cell Line, Tumor; Cell Proliferation; Enhancer of Zeste Homolog 2 Protein; Gene Expression Regulation, Neoplastic; HEK293 Cells; Histone Methyltransferases; Humans; Male; Methylation; Mice, Inbred NOD; Polycomb Repressive Complex 2; Prostatic Neoplasms; Protein Binding; Receptors, Androgen; RNA, Messenger; Signal Transduction; Trans-Activators; Transcription, Genetic | 2018 |
Targeting the lysosome by an aminomethylated Riccardin D triggers DNA damage through cathepsin B-mediated degradation of BRCA1.
Topics: Amines; Apoptosis; BRCA1 Protein; Cathepsin B; Cell Membrane Permeability; DNA Damage; Humans; Lysosomes; Male; Methylation; Phenyl Ethers; Prostatic Neoplasms; Proteolysis; Stilbenes; Tumor Cells, Cultured | 2019 |
BRCA1 and EZH2 cooperate in regulation of prostate cancer stem cell phenotype.
Topics: Aldehyde Oxidoreductases; Animals; BRCA1 Protein; Cell Line, Tumor; Enhancer of Zeste Homolog 2 Protein; Gene Expression Regulation, Neoplastic; Histones; Humans; Male; Methylation; Mice; Neoplasm Transplantation; Neoplastic Stem Cells; Polycomb Repressive Complex 2; Prostatic Neoplasms | 2019 |
miR-193a targets MLL1 mRNA and drastically decreases MLL1 protein production: Ectopic expression of the miRNA aberrantly lowers H3K4me3 content of the chromatin and hampers cell proliferation and viability.
Topics: 3' Untranslated Regions; Caveolin 1; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chromatin; Down-Regulation; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Histone-Lysine N-Methyltransferase; Histones; Humans; Male; Methylation; MicroRNAs; Myeloid-Lymphoid Leukemia Protein; Prostatic Neoplasms | 2019 |
A novel combined miRNA and methylation marker panel (miMe) for prediction of prostate cancer outcome after radical prostatectomy.
Topics: Adult; Aged; Biomarkers, Tumor; Cohort Studies; Disease Progression; Humans; Kaplan-Meier Estimate; Male; Methylation; MicroRNAs; Middle Aged; Neoplasm Recurrence, Local; Nomograms; Prognosis; Prostate; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms; Risk Factors | 2019 |
Sulforaphane enhances Nrf2 expression in prostate cancer TRAMP C1 cells through epigenetic regulation.
Topics: Animals; Anticarcinogenic Agents; Cell Line, Tumor; CpG Islands; Epigenesis, Genetic; Isothiocyanates; Male; Methylation; Mice; NF-E2-Related Factor 2; Prostatic Neoplasms; Sulfoxides; Thiocyanates | 2013 |
Liver x receptors protect from development of prostatic intra-epithelial neoplasia in mice.
Topics: Animals; Carcinoma; Cholesterol; Diet, High-Fat; Down-Regulation; Enhancer of Zeste Homolog 2 Protein; Gene Expression Regulation, Neoplastic; Histones; Homeodomain Proteins; Humans; Liver X Receptors; Male; Methylation; Mice; Mice, Knockout; Neoplasms, Experimental; Orphan Nuclear Receptors; Polycomb Repressive Complex 2; Prostatic Intraepithelial Neoplasia; Prostatic Neoplasms; Prostatic Secretory Proteins; Transcription Factors | 2013 |
Overexpression of MYC and EZH2 cooperates to epigenetically silence MST1 expression.
Topics: Cell Line, Tumor; Cell Proliferation; Enhancer of Zeste Homolog 2 Protein; Epigenesis, Genetic; Gene Silencing; Histones; Humans; Intracellular Signaling Peptides and Proteins; Male; Methylation; Polycomb Repressive Complex 2; Prostatic Neoplasms; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins c-myc | 2014 |
A role for WDR5 in integrating threonine 11 phosphorylation to lysine 4 methylation on histone H3 during androgen signaling and in prostate cancer.
Topics: Androgens; Cell Line, Tumor; Cell Proliferation; Chromatin; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; HeLa Cells; Histone-Lysine N-Methyltransferase; Histones; Humans; Intracellular Signaling Peptides and Proteins; Lysine; Male; Methylation; Myeloid-Lymphoid Leukemia Protein; Phosphorylation; Prostatic Neoplasms; Protein Kinase C; Receptors, Androgen; Signal Transduction; Threonine | 2014 |
Polycomb protein EZH2 suppresses apoptosis by silencing the proapoptotic miR-31.
Topics: Apoptosis; Cell Line, Tumor; Docetaxel; Down-Regulation; Drug Resistance, Neoplasm; Enhancer of Zeste Homolog 2 Protein; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Gene Silencing; Histones; Humans; Male; Methylation; MicroRNAs; Models, Biological; Polycomb Repressive Complex 2; Promoter Regions, Genetic; Prostatic Neoplasms; RNA, Small Interfering; Taxoids | 2014 |
Profiling and relative quantitation of phosphoinositides by multiple precursor ion scanning based on phosphate methylation and isotopic labeling.
Topics: Animals; Cattle; Chromatography, Liquid; Diazomethane; Humans; Isotope Labeling; Lipids; Male; Methylation; Phosphates; Phosphatidylinositols; Prostatic Neoplasms; Spectrometry, Mass, Secondary Ion | 2015 |
RUNX1, an androgen- and EZH2-regulated gene, has differential roles in AR-dependent and -independent prostate cancer.
Topics: Aged; Androgens; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Core Binding Factor Alpha 2 Subunit; Dihydrotestosterone; Enhancer of Zeste Homolog 2 Protein; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; HEK293 Cells; Histones; Humans; Immunohistochemistry; Male; Methylation; Middle Aged; Polycomb Repressive Complex 2; Prognosis; Prostatic Neoplasms; Protein Binding; Receptors, Androgen; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; Survival Analysis | 2015 |
Quantitative urinary proteomics using stable isotope labelling by peptide dimethylation in patients with prostate cancer.
Topics: Adult; Aged; Amino Acid Sequence; Amino Acids; Biomarkers, Tumor; Bone Neoplasms; Chromatography, Liquid; Humans; Isotope Labeling; Male; Methylation; Middle Aged; Molecular Sequence Data; Osteopontin; Prostatic Hyperplasia; Prostatic Neoplasms; Proteomics; Prothrombin; Reference Values; Tandem Mass Spectrometry | 2015 |
Exposure of Human Prostaspheres to Bisphenol A Epigenetically Regulates SNORD Family Noncoding RNAs via Histone Modification.
Topics: Benzhydryl Compounds; Cluster Analysis; CpG Islands; DNA Methylation; Dose-Response Relationship, Drug; Epigenesis, Genetic; Epithelial Cells; Estradiol; Estrogens; Estrogens, Non-Steroidal; Histone Code; Histones; Humans; Lysine; Male; Methylation; Phenols; Prostate; Prostatic Neoplasms; Reverse Transcriptase Polymerase Chain Reaction; RNA, Untranslated; Stem Cells; Transcriptome | 2015 |
Application of Mannich bases to the synthesis of hydroxymethylated isoflavonoids as potential antineoplastic agents.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Humans; Hydroxylation; Isoflavones; Male; Mannich Bases; Methylation; Prostate; Prostatic Neoplasms | 2015 |
Sulforaphane modulates telomerase activity via epigenetic regulation in prostate cancer cell lines.
Topics: Acetylation; Cell Line, Tumor; Chromatin; Chromatin Immunoprecipitation; Epigenesis, Genetic; Histone Deacetylase Inhibitors; Histones; Humans; Isothiocyanates; Lysine; Male; Methyl-CpG-Binding Protein 2; Methylation; Nucleosomes; Phytochemicals; Promoter Regions, Genetic; Prostatic Neoplasms; Protein Processing, Post-Translational; Sulfoxides; Telomerase; Transcription, Genetic | 2016 |
Aberrant Protocadherin17 (PCDH17) Methylation in Serum is a Potential Predictor for Recurrence of Early-Stage Prostate Cancer Patients After Radical Prostatectomy.
Topics: Aged; Biomarkers, Tumor; Cadherins; Humans; Male; Methylation; Neoplasm Recurrence, Local; Prostatectomy; Prostatic Neoplasms | 2015 |
SET8 induces epithelial‑mesenchymal transition and enhances prostate cancer cell metastasis by cooperating with ZEB1.
Topics: Cadherins; Cell Line, Tumor; Epithelial-Mesenchymal Transition; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Histone-Lysine N-Methyltransferase; Histones; Homeodomain Proteins; Humans; Lysine; Male; Methylation; Neoplasm Metastasis; Prostatic Neoplasms; Protein Binding; Transcription Factors; Transcription, Genetic; Vimentin; Zinc Finger E-box-Binding Homeobox 1 | 2016 |
Assembly of methylated KDM1A and CHD1 drives androgen receptor-dependent transcription and translocation.
Topics: Cell Line; Crystallography, X-Ray; DNA Helicases; DNA-Binding Proteins; Gene Expression Regulation, Neoplastic; Histocompatibility Antigens; Histone Demethylases; Histone-Lysine N-Methyltransferase; Humans; Male; Methylation; Models, Molecular; Oncogene Proteins, Fusion; Prostatic Neoplasms; Receptors, Androgen; Transcription, Genetic; Translocation, Genetic | 2016 |
Hypoacetylation, hypomethylation, and dephosphorylation of H2B histones and excessive histone deacetylase activity in DU-145 prostate cancer cells.
Topics: Acetylation; Amino Acid Sequence; Butyric Acid; Cell Line; Cell Line, Tumor; Chromatography, Liquid; Histone Deacetylase Inhibitors; Histone Deacetylases; Histones; Humans; Lysine; Male; Methylation; Molecular Sequence Data; Phosphorylation; Prostatic Neoplasms; Protein Processing, Post-Translational; Tandem Mass Spectrometry; Threonine | 2016 |
Prognostic Value of Protocadherin10 (PCDH10) Methylation in Serum of Prostate Cancer Patients.
Topics: Aged; Cadherins; Disease-Free Survival; Humans; Male; Methylation; Multivariate Analysis; Polymerase Chain Reaction; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Prostatectomy; Prostatic Neoplasms; Protocadherins | 2016 |
Nephrotoxicity of epigenetic inhibitors used for the treatment of cancer.
Topics: Acetylation; Animals; Antineoplastic Agents; Azacitidine; Cell Death; Cell Line, Tumor; Cell Proliferation; Cisplatin; Cyclin-Dependent Kinase Inhibitor p21; Docetaxel; Epigenesis, Genetic; HEK293 Cells; Histones; Humans; Hydroxamic Acids; Kidney; Male; Methylation; Neoplasms; Oligopeptides; Prostatic Neoplasms; Rats; Taxoids | 2016 |
Role of RbBP5 and H3K4me3 in the vicinity of Snail transcription start site during epithelial-mesenchymal transition in prostate cancer cell.
Topics: Cell Line, Tumor; DNA-Binding Proteins; Epigenesis, Genetic; Epithelial-Mesenchymal Transition; Histones; Humans; Male; Methylation; Multiprotein Complexes; Nuclear Proteins; Peptide Fragments; Prostatic Neoplasms; Protein Binding; RNA, Small Interfering; Sialoglycoproteins; Smad2 Protein; Smad3 Protein; Snail Family Transcription Factors; Transcription Initiation Site; Transforming Growth Factor beta | 2016 |
DNMT1 Regulates Epithelial-Mesenchymal Transition and Cancer Stem Cells, Which Promotes Prostate Cancer Metastasis.
Topics: Animals; Biomarkers; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Transformation, Neoplastic; Disease Models, Animal; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; Epithelial-Mesenchymal Transition; Gene Silencing; Histones; Homeodomain Proteins; Humans; Kruppel-Like Factor 4; Kruppel-Like Transcription Factors; Male; Methylation; Mice; Neoplasm Metastasis; Neoplastic Stem Cells; Promoter Regions, Genetic; Prostatic Neoplasms; Protein Kinase C-alpha; Repressor Proteins; RNA Interference; Spheroids, Cellular; Tumor Burden; Tumor Cells, Cultured; Xenograft Model Antitumor Assays; Zinc Finger E-box Binding Homeobox 2 | 2016 |
Methylated urolithin A, the modified ellagitannin-derived metabolite, suppresses cell viability of DU145 human prostate cancer cells via targeting miR-21.
Topics: Animals; Apoptosis; Apoptosis Regulatory Proteins; beta Catenin; Blotting, Western; Cell Proliferation; Coumarins; Forkhead Box Protein O3; Gene Expression Regulation, Neoplastic; Hepatocyte Nuclear Factor 1-alpha; Humans; Lymphoid Enhancer-Binding Factor 1; Male; Methylation; Mice; Mice, Inbred BALB C; Mice, Nude; MicroRNAs; Prostatic Neoplasms; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA-Binding Proteins; RNA, Messenger; Tumor Cells, Cultured; Wnt Signaling Pathway; Xenograft Model Antitumor Assays | 2016 |
P110β Inhibition Reduces Histone H3K4 Di-Methylation in Prostate Cancer.
Topics: Cell Line, Tumor; Class I Phosphatidylinositol 3-Kinases; Histones; Humans; Male; Methylation; Morpholines; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Prostatic Neoplasms; Pyrimidinones | 2017 |
A Novel Role of Silibinin as a Putative Epigenetic Modulator in Human Prostate Carcinoma.
Topics: Antineoplastic Agents; Antioxidants; Cell Line, Tumor; DNA (Cytosine-5-)-Methyltransferases; Enhancer of Zeste Homolog 2 Protein; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Histone Deacetylase 1; Histone Deacetylase 2; Histones; Humans; Male; Methylation; Neoplasm Proteins; Phosphorylation; Polycomb Repressive Complex 2; Prostatic Neoplasms; Proto-Oncogene Proteins c-akt; Real-Time Polymerase Chain Reaction; Silybin; Silymarin; Transcription Factors | 2016 |
Synthetic essentiality of chromatin remodelling factor CHD1 in PTEN-deficient cancer.
Topics: beta-Transducin Repeat-Containing Proteins; Breast Neoplasms; Cell Line, Tumor; Chromatin Assembly and Disassembly; DNA Helicases; DNA-Binding Proteins; Female; Gene Expression Regulation, Neoplastic; Genes, Essential; Glycogen Synthase Kinase 3 beta; Histones; Humans; Lysine; Male; Methylation; Molecular Targeted Therapy; Neoplasms; NF-kappa B; Phosphorylation; Prostatic Neoplasms; Proteasome Endopeptidase Complex; Protein Stability; Proteolysis; PTEN Phosphohydrolase; Tumor Necrosis Factor-alpha; Ubiquitination | 2017 |
Unmethylated E-cadherin gene expression is significantly associated with metastatic human prostate cancer cells in bone.
Topics: Biopsy; Bone Neoplasms; Cadherins; Carcinoma; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Male; Methylation; Polymerase Chain Reaction; Prostatic Hyperplasia; Prostatic Neoplasms; Tissue Distribution | 2008 |
Genomic loss of microRNA-101 leads to overexpression of histone methyltransferase EZH2 in cancer.
Topics: 3' Untranslated Regions; Algorithms; Breast Neoplasms; Cell Line, Tumor; Disease Progression; DNA-Binding Proteins; Enhancer of Zeste Homolog 2 Protein; Epigenesis, Genetic; Female; Gene Expression Regulation, Neoplastic; Genome, Human; Histones; Humans; Lysine; Male; Methylation; MicroRNAs; Neoplasm Metastasis; Neoplasms; Polycomb Repressive Complex 2; Promoter Regions, Genetic; Prostatic Neoplasms; RNA, Small Interfering; Stomach Neoplasms; Transcription Factors | 2008 |
Methylation-mediated repression of GADD45alpha in prostate cancer and its role as a potential therapeutic target.
Topics: Antineoplastic Agents; Azacitidine; Cell Cycle Proteins; Cell Line, Tumor; DNA Methylation; DNA Primers; DNA, Neoplasm; Docetaxel; Gene Expression Regulation, Neoplastic; Genome; Humans; Male; Methylation; Nuclear Proteins; Prostatic Neoplasms; Reverse Transcriptase Polymerase Chain Reaction; Taxoids; Up-Regulation | 2009 |
Genome-wide profiling of histone h3 lysine 4 and lysine 27 trimethylation reveals an epigenetic signature in prostate carcinogenesis.
Topics: Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Genome, Human; Histones; Humans; Immunoprecipitation; Lysine; Male; Methylation; MicroRNAs; Oligonucleotide Array Sequence Analysis; Prostatic Neoplasms | 2009 |
Global levels of histone modifications predict prognosis in different cancers.
Topics: Acetylation; Adenocarcinoma; Adult; Aged; Aged, 80 and over; Blotting, Western; Cell Proliferation; Chromatin Immunoprecipitation; Cohort Studies; Female; Histones; Humans; Immunoenzyme Techniques; Kidney Neoplasms; Lung Neoplasms; Male; Methylation; Middle Aged; Prognosis; Promoter Regions, Genetic; Prostatic Neoplasms; Protein Processing, Post-Translational; Repetitive Sequences, Nucleic Acid; Tissue Array Analysis | 2009 |
DNA methylation and histone modification regulate silencing of OPG during tumor progression.
Topics: Cell Line, Tumor; DNA Methylation; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Gene Silencing; Histones; Humans; Male; Methylation; Neoplasms; Osteoprotegerin; Prostatic Neoplasms | 2009 |
The presence of RNA polymerase II, active or stalled, predicts epigenetic fate of promoter CpG islands.
Topics: Cell Line; Cell Line, Tumor; Chromatin Immunoprecipitation; CpG Islands; DNA Methylation; Female; Genetic Predisposition to Disease; Histones; Humans; Lysine; Male; Methylation; Oligonucleotide Array Sequence Analysis; Promoter Regions, Genetic; Prostatic Neoplasms; Protein Binding; RNA Polymerase II; Transcription, Genetic | 2009 |
DNA condensation by chiral alpha-methylated polyamine analogues and protection of cellular DNA from oxidative damage.
Topics: DNA; DNA Damage; Humans; Indicators and Reagents; Male; Methylation; Oxidation-Reduction; Prostatic Neoplasms; Spermine; Tumor Cells, Cultured | 2010 |
Consolidation of the cancer genome into domains of repressive chromatin by long-range epigenetic silencing (LRES) reduces transcriptional plasticity.
Topics: Acetylation; Cell Line, Tumor; Chromatin Assembly and Disassembly; Computational Biology; CpG Islands; Databases, Genetic; DNA Methylation; Down-Regulation; Embryonic Stem Cells; Gene Deletion; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Silencing; Genes; Genome, Human; Histones; Humans; Loss of Heterozygosity; Male; Methylation; MicroRNAs; Multigene Family; Neoplasms; Promoter Regions, Genetic; Prostatic Neoplasms; RNA, Messenger; Transcription, Genetic; Up-Regulation | 2010 |
Establishment and characterization of multi-drug resistant, prostate carcinoma-initiating stem-like cells from human prostate cancer cell lines 22RV1.
Topics: Acetylation; Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Azacitidine; Biomarkers, Tumor; Cell Line, Tumor; Cell Proliferation; CpG Islands; Decitabine; DNA Methylation; DNA Modification Methylases; Drug Resistance, Neoplasm; Enzyme Inhibitors; Epigenesis, Genetic; Histones; Humans; Male; Methylation; Mice; Mice, Nude; Neoplasm Proteins; Neoplastic Stem Cells; Promoter Regions, Genetic; Prostatic Neoplasms; Protein Processing, Post-Translational; Proto-Oncogene Proteins c-kit; Time Factors; Tumor Burden | 2010 |
Phosphorylation of histone H3T6 by PKCbeta(I) controls demethylation at histone H3K4.
Topics: Androgens; Animals; Cell Division; Cell Line, Tumor; Chromatin; Gene Expression Regulation; Gene Knockdown Techniques; Histone Demethylases; Histones; Humans; Lysine; Male; Methylation; Mice; Mice, Nude; Mice, SCID; Phosphorylation; Phosphothreonine; Promoter Regions, Genetic; Prostatic Neoplasms; Protein Kinase C; Protein Kinase C beta; Signal Transduction; Xenograft Model Antitumor Assays | 2010 |
ETS transcription factors control transcription of EZH2 and epigenetic silencing of the tumor suppressor gene Nkx3.1 in prostate cancer.
Topics: Aged; Anoikis; Cell Movement; DNA-Binding Proteins; Enhancer of Zeste Homolog 2 Protein; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Gene Silencing; Histones; Homeodomain Proteins; Humans; Lysine; Male; Methylation; Middle Aged; Models, Genetic; Polycomb Repressive Complex 2; Prostatic Neoplasms; Proto-Oncogene Proteins c-ets; Trans-Activators; Transcription Factors; Transcription, Genetic; Transcriptional Regulator ERG; Tumor Suppressor Proteins; Up-Regulation | 2010 |
Molecular interplay of the noncoding RNA ANRIL and methylated histone H3 lysine 27 by polycomb CBX7 in transcriptional silencing of INK4a.
Topics: Animals; Cell Line, Tumor; Cellular Senescence; Cyclin-Dependent Kinase Inhibitor p15; Cyclin-Dependent Kinase Inhibitor p16; Gene Silencing; Histones; Humans; Lysine; Male; Methylation; Models, Molecular; Molecular Sequence Data; Multigene Family; Nuclear Magnetic Resonance, Biomolecular; Polycomb Repressive Complex 1; Polycomb-Group Proteins; Prostatic Neoplasms; Protein Structure, Tertiary; Repressor Proteins; RNA, Untranslated; Transcription, Genetic | 2010 |
Gene expression correlation analysis predicts involvement of high- and low-confidence risk genes in different stages of prostate carcinogenesis.
Topics: DNA Methylation; Genetic Predisposition to Disease; Histones; Humans; Male; Metaplasia; Methylation; Neoplasm Staging; Oligonucleotide Array Sequence Analysis; Prostate; Prostatic Neoplasms; Receptors, Androgen; Receptors, Estrogen; Risk Assessment; Stem Cells | 2010 |
Post-treatment circulating plasma BMP6 mRNA and H3K27 methylation levels discriminate metastatic prostate cancer from localized disease.
Topics: Aged; Biomarkers; Bone Morphogenetic Protein 6; Diagnosis, Differential; Histones; Humans; Male; Methylation; Neoplasm Metastasis; Neoplasm Staging; Prostatic Neoplasms; RNA, Messenger | 2010 |
Use of a combination of biomarkers in serum and urine to improve detection of prostate cancer.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Glutathione S-Transferase pi; Humans; Male; Matrix Metalloproteinase 2; Methylation; Middle Aged; Predictive Value of Tests; Prostate-Specific Antigen; Prostatic Neoplasms; Racemases and Epimerases; Retrospective Studies; Sensitivity and Specificity; Tumor Suppressor Proteins | 2010 |
Re: Post-treatment circulating plasma BMP6 mRNA and H3K27 methylation levels discriminate metastatic prostate cancer from localized disease.
Topics: Bone Morphogenetic Protein 6; Diagnosis, Differential; Histones; Humans; Male; Methylation; Neoplasm Metastasis; Prostatic Neoplasms; RNA, Messenger | 2010 |
Regulation of the androgen receptor by SET9-mediated methylation.
Topics: Active Transport, Cell Nucleus; Cell Line, Tumor; Cell Nucleus; Cell Proliferation; Histone-Lysine N-Methyltransferase; Histones; Humans; Lysine; Male; Methylation; Prostate-Specific Antigen; Prostatic Neoplasms; Receptors, Androgen; Transcriptional Activation | 2011 |
Energy restriction-mimetic agents induce apoptosis in prostate cancer cells in part through epigenetic activation of KLF6 tumor suppressor gene expression.
Topics: Acetylation; Apoptosis; Cell Line, Tumor; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Histone Deacetylases; Histones; Humans; Hypoglycemic Agents; Kruppel-Like Factor 6; Kruppel-Like Transcription Factors; Male; Methylation; Prostatic Neoplasms; Proto-Oncogene Proteins; Response Elements; Sp1 Transcription Factor; Thiazolidinediones; Tumor Suppressor Proteins | 2011 |
Pharmacologic disruption of Polycomb Repressive Complex 2 inhibits tumorigenicity and tumor progression in prostate cancer.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Movement; Cell Survival; Cell Transformation, Neoplastic; Disease Progression; Gene Expression Regulation, Neoplastic; Histones; Humans; Male; Methylation; Mice; Mice, SCID; Neoplastic Stem Cells; Polycomb-Group Proteins; Prostatic Neoplasms; Repressor Proteins; RNA, Messenger; Spheroids, Cellular; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2011 |
Metabolomic profiling reveals a role for androgen in activating amino acid metabolism and methylation in prostate cancer cells.
Topics: Amino Acids; Androgens; Cell Line, Tumor; Humans; Male; Metabolome; Metabolomics; Methylation; Models, Biological; Organ Specificity; Phenotype; Prostate; Prostatic Neoplasms | 2011 |
Histone demethylation and steroid receptor function in cancer.
Topics: Animals; Breast Neoplasms; Female; Gene Expression Regulation, Neoplastic; Histone Demethylases; Histone-Lysine N-Methyltransferase; Histones; Humans; Male; Methylation; Prostatic Neoplasms; Receptors, Steroid | 2012 |
Dynamic nucleosome-depleted regions at androgen receptor enhancers in the absence of ligand in prostate cancer cells.
Topics: Acetylation; Acetyltransferases; Androgens; Cell Line, Tumor; Chromatin Immunoprecipitation; CpG Islands; Dihydrotestosterone; Enhancer Elements, Genetic; GATA2 Transcription Factor; Gene Expression; Gene Expression Regulation, Neoplastic; Histones; Humans; Ligands; Male; Methylation; Methyltransferases; Nucleosomes; Prostate-Specific Antigen; Prostatic Neoplasms; Receptors, Androgen; Sequence Analysis, DNA; Serine Endopeptidases; Tissue Kallikreins | 2011 |
Androgen receptor gene expression in prostate cancer is directly suppressed by the androgen receptor through recruitment of lysine-specific demethylase 1.
Topics: Androgens; Cell Line, Tumor; Enhancer Elements, Genetic; Gene Expression Regulation, Neoplastic; Histone Demethylases; Histones; Humans; Male; Methylation; Prostatic Neoplasms; Receptors, Androgen; RNA, Messenger | 2011 |
A cell-based high-throughput screening assay to measure cellular histone h3 lys27 trimethylation with a modified dissociation-enhanced lanthanide fluorescent immunoassay.
Topics: Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Enzyme Inhibitors; Fluorescent Antibody Technique; High-Throughput Screening Assays; Histone Methyltransferases; Histone-Lysine N-Methyltransferase; Histones; Humans; Lanthanoid Series Elements; Lysine; Male; Methylation; Prostatic Neoplasms | 2012 |
[Molecular pathology of multifocal prostate cancer and its clinical application].
Topics: Aneuploidy; Gene Rearrangement; Glutathione S-Transferase pi; Humans; Male; Methylation; Neoplasm Grading; Neoplasm Staging; Neoplasms, Multiple Primary; Oncogene Proteins, Fusion; Prostate-Specific Antigen; Prostatic Intraepithelial Neoplasia; Prostatic Neoplasms | 2011 |
Global histone H3K27 methylation levels are different in localized and metastatic prostate cancer.
Topics: Histones; Humans; Male; Methylation; Neoplasm Metastasis; Neoplasm Recurrence, Local; Prostatic Neoplasms | 2012 |
Histone H2B ubiquitin ligases RNF20 and RNF40 in androgen signaling and prostate cancer cell growth.
Topics: Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Genes, Reporter; Histones; Humans; Luciferases; Male; Methylation; Prostate-Specific Antigen; Prostatic Neoplasms; Protein Binding; Receptors, Androgen; Response Elements; Signal Transduction; Tacrolimus Binding Proteins; Testosterone; Transcription, Genetic; Ubiquitin-Protein Ligases; Ubiquitination | 2012 |
Impairment of prostate cancer cell growth by a selective and reversible lysine-specific demethylase 1 inhibitor.
Topics: Androgens; Animals; Cell Growth Processes; Cell Line, Tumor; Chromatin; Enzyme Inhibitors; Histone Demethylases; Histones; Humans; Male; Methylation; Mice; Mice, Nude; Prostatic Neoplasms; Protein Processing, Post-Translational; Pyrones; Receptors, Androgen; Xenograft Model Antitumor Assays | 2012 |
Quercetin increased the antiproliferative activity of green tea polyphenol (-)-epigallocatechin gallate in prostate cancer cells.
Topics: Androgens; Anticarcinogenic Agents; Catechin; Catechol O-Methyltransferase; Catechol O-Methyltransferase Inhibitors; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Drug Synergism; Humans; Male; Methylation; Prostatic Neoplasms; Quercetin; Tea | 2012 |
Global levels of H3K27me3 track with differentiation in vivo and are deregulated by MYC in prostate cancer.
Topics: Animals; Cell Compartmentation; Cell Differentiation; Cell Line, Tumor; Enhancer of Zeste Homolog 2 Protein; Histones; Humans; Immunohistochemistry; Inflammation; Lysine; Male; Methylation; Mice; Organ Specificity; Polycomb Repressive Complex 2; Prostate; Prostatectomy; Prostatic Neoplasms; Protein Processing, Post-Translational; Proto-Oncogene Proteins c-myc; RNA, Small Interfering; Stem Cells; Tissue Array Analysis | 2012 |
The histone methyltransferase MMSET/WHSC1 activates TWIST1 to promote an epithelial-mesenchymal transition and invasive properties of prostate cancer.
Topics: Cell Line, Tumor; Cell Movement; Epigenesis, Genetic; Epithelial-Mesenchymal Transition; Gene Expression; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Histone-Lysine N-Methyltransferase; Histones; Humans; Male; Methylation; Neoplasm Invasiveness; Nuclear Proteins; Prostatic Neoplasms; Protein Binding; Protein Processing, Post-Translational; Repressor Proteins; RNA, Small Interfering; Twist-Related Protein 1 | 2013 |
Chromatin organization is a major influence on regional mutation rates in human cancer cells.
Topics: Animals; CpG Islands; Epigenesis, Genetic; Euchromatin; Genome, Human; Heterochromatin; Histones; Humans; Leukemia; Lung Neoplasms; Male; Melanoma; Methylation; Mutagenesis; Mutation Rate; Neoplasms; Pan troglodytes; Polymorphism, Single Nucleotide; Principal Component Analysis; Prostatic Neoplasms; Small Cell Lung Carcinoma | 2012 |
Suppression of metallothionein-I/II expression and its probable molecular mechanisms.
Topics: Animals; Carcinoma, Hepatocellular; CCAAT-Enhancer-Binding Proteins; Cytosine; DNA-Binding Proteins; Down-Regulation; Humans; Lymphoma, Non-Hodgkin; Male; Metallothionein; Methylation; Mice; NFI Transcription Factors; Nuclear Proteins; Promoter Regions, Genetic; Prostatic Neoplasms; Rats; Transcription Factors; Tumor Cells, Cultured; Y-Box-Binding Protein 1 | 2002 |
During apoptosis of tumor cells HMGA1a protein undergoes methylation: identification of the modification site by mass spectrometry.
Topics: Amino Acid Sequence; Animals; Apoptosis; Arginine; Base Sequence; Binding Sites; DNA, Complementary; HL-60 Cells; HMGA1a Protein; Humans; Male; Mass Spectrometry; Methylation; Molecular Sequence Data; Peptide Mapping; Prostatic Neoplasms; Rats; Recombinant Proteins; Sequence Homology, Amino Acid; Tumor Cells, Cultured | 2003 |
Cytotoxic flavone analogues of vitexicarpin, a constituent of the leaves of Vitex negundo.
Topics: Acylation; Animals; Antineoplastic Agents, Phytogenic; Colonic Neoplasms; Disease Models, Animal; Drug Screening Assays, Antitumor; Flavonoids; Humans; Indonesia; Inhibitory Concentration 50; Leukemia P388; Lung Neoplasms; Male; Methylation; Mice; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Plant Leaves; Plants, Medicinal; Prostatic Neoplasms; Tumor Cells, Cultured; Vitex | 2003 |
Prostate cancer detection by GSTP1 methylation analysis of postbiopsy urine specimens.
Topics: Aged; Aged, 80 and over; Biopsy; Cohort Studies; DNA; DNA Methylation; Glutathione S-Transferase pi; Glutathione Transferase; Humans; Isoenzymes; Male; Methylation; Middle Aged; Polymerase Chain Reaction; Prostatic Intraepithelial Neoplasia; Prostatic Neoplasms; Risk; Sensitivity and Specificity; Sulfites | 2003 |
Quantitative GSTP1 methylation and the detection of prostate adenocarcinoma in sextant biopsies.
Topics: Adenocarcinoma; Biomarkers, Tumor; Biopsy, Needle; DNA, Neoplasm; Glutathione S-Transferase pi; Glutathione Transferase; Humans; Isoenzymes; Male; Methylation; Polymerase Chain Reaction; Promoter Regions, Genetic; Prostatic Neoplasms; Sensitivity and Specificity | 2003 |
Quantitative GSTP1 methylation levels correlate with Gleason grade and tumor volume in prostate needle biopsies.
Topics: Acyltransferases; Biopsy, Needle; Diagnosis, Differential; Humans; Male; Methylation; Prostatic Neoplasms | 2004 |
14-3-3sigma is down-regulated in human prostate cancer.
Topics: 14-3-3 Proteins; Apoptosis Regulatory Proteins; Biomarkers, Tumor; Cell Line, Tumor; Cell Transformation, Neoplastic; Cysteine Endopeptidases; Down-Regulation; Exonucleases; Exoribonucleases; Gene Expression Regulation, Neoplastic; Gene Silencing; Humans; Male; Membrane Glycoproteins; Methylation; Multienzyme Complexes; Neoplasm Proteins; Prostatic Neoplasms; Proteasome Endopeptidase Complex; Protein Isoforms; TNF-Related Apoptosis-Inducing Ligand; Tumor Necrosis Factor-alpha | 2004 |
Coregulator recruitment and histone modifications in transcriptional regulation by the androgen receptor.
Topics: Acetylation; Androgen Receptor Antagonists; Anilides; Cell Line, Tumor; Chromatin Immunoprecipitation; Cyproterone Acetate; DNA Polymerase II; Enhancer Elements, Genetic; Gene Expression Regulation; Histones; Humans; Male; Methylation; Mifepristone; Nitriles; Nuclear Proteins; Nuclear Receptor Coactivator 2; Promoter Regions, Genetic; Prostate-Specific Antigen; Prostatic Neoplasms; Protein-Arginine N-Methyltransferases; Receptors, Androgen; Tissue Kallikreins; Tosyl Compounds; Trans-Activators; Transcription Factors; Transcription, Genetic | 2004 |
Prostate cancer molecular markers GSTP1 and hTERT in expressed prostatic secretions as predictors of biopsy results.
Topics: Adenocarcinoma; Biomarkers, Tumor; Biopsy, Needle; Body Fluids; DNA-Binding Proteins; Glutathione S-Transferase pi; Glutathione Transferase; Humans; Isoenzymes; Male; Methylation; Neoplasm Proteins; Predictive Value of Tests; Prostatic Neoplasms; Protein Processing, Post-Translational; Sensitivity and Specificity; Telomerase | 2004 |
Chemo-enzymatic synthesis and cell-growth inhibition activity of resveratrol analogues.
Topics: Anticarcinogenic Agents; Candida; Catalysis; Cell Division; Fibroblasts; Humans; Hydrogenation; Lipase; Male; Methylation; Molecular Structure; Prostatic Neoplasms; Resveratrol; Stilbenes; Tumor Cells, Cultured | 2005 |
Developmental biology. Combing over the Polycomb group proteins.
Topics: Animals; Chromatin; DNA-Directed RNA Polymerases; Dosage Compensation, Genetic; Drosophila; Drosophila Proteins; Gene Expression Regulation, Developmental; Gene Silencing; Histones; Humans; Male; Methylation; Mutation; Neoplasms; Nucleosomes; Pluripotent Stem Cells; Polycomb Repressive Complex 1; Polycomb-Group Proteins; Prostatic Neoplasms; Proteins; Repressor Proteins; Transcription, Genetic; Ubiquitin | 2005 |
[Study on the diagnosis of prostatic cancer by detecting methylated GSTP1 promotor region from the urinary samples].
Topics: Aged; Aged, 80 and over; DNA; Glutathione S-Transferase pi; Glutathione Transferase; Humans; Isoenzymes; Male; Methylation; Middle Aged; Polymerase Chain Reaction; Promoter Regions, Genetic; Prostatectomy; Prostatic Neoplasms | 2005 |
Cancer: a changing global view.
Topics: Acetylation; Gene Expression Regulation, Neoplastic; Histones; Humans; Male; Methylation; Neoplasm Recurrence, Local; Prognosis; Prostatic Neoplasms; Protein Processing, Post-Translational | 2005 |
Global histone modification patterns predict risk of prostate cancer recurrence.
Topics: Acetylation; Gene Expression Regulation, Neoplastic; Histones; Humans; Immunohistochemistry; Male; Methylation; Neoplasm Recurrence, Local; Prognosis; Proportional Hazards Models; Prostatic Neoplasms; Protein Processing, Post-Translational; Recurrence | 2005 |
LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent transcription.
Topics: Androgens; Animals; Cell Line; Cell Line, Tumor; Cell Proliferation; Chromatin; Gene Expression Profiling; Gene Expression Regulation; Histone Demethylases; Histones; Humans; Immunoprecipitation; Male; Methylation; Mice; Oxidoreductases, N-Demethylating; Pargyline; Prostate; Prostatic Neoplasms; Protein Binding; Receptors, Androgen; RNA, Messenger; Transcription, Genetic; Transcriptional Activation | 2005 |
Epigenetic heterogeneity of high-grade prostatic intraepithelial neoplasia: clues for clonal progression in prostate carcinogenesis.
Topics: Aged; Alleles; Cell Transformation, Neoplastic; Clone Cells; Cluster Analysis; Disease Progression; Epigenesis, Genetic; Humans; Male; Methylation; Middle Aged; Neoplasm Proteins; Polymerase Chain Reaction; Prostatic Intraepithelial Neoplasia; Prostatic Neoplasms | 2006 |
Histone H3 lysine 9 methyltransferase G9a is a transcriptional coactivator for nuclear receptors.
Topics: Acyltransferases; Animals; Arginine; Cell Line, Tumor; Chlorocebus aethiops; COS Cells; Estrogen Receptor alpha; Genes, Reporter; Histone Methyltransferases; Histone-Lysine N-Methyltransferase; Humans; Luciferases; Male; Methylation; Nuclear Receptor Coactivator 2; p300-CBP Transcription Factors; Prostatic Neoplasms; Protein Methyltransferases; Protein-Arginine N-Methyltransferases; Receptors, Cytoplasmic and Nuclear; Recombinant Fusion Proteins; Repressor Proteins; RNA, Small Interfering; Trans-Activators; Transcriptional Activation | 2006 |
Involvement of arginine methyltransferase CARM1 in androgen receptor function and prostate cancer cell viability.
Topics: Androgens; Apoptosis; Cell Line, Tumor; Cell Nucleus; Cell Proliferation; Cell Survival; Cells, Cultured; Disease Progression; Gene Expression Regulation, Neoplastic; Histones; Humans; Male; Methylation; Prostatic Neoplasms; Protein-Arginine N-Methyltransferases; Receptors, Androgen | 2006 |
Locus-wide chromatin remodeling and enhanced androgen receptor-mediated transcription in recurrent prostate tumor cells.
Topics: Acetylation; Androgens; Animals; Chromatin; Chromatin Assembly and Disassembly; Dihydrotestosterone; Genes, Reporter; Histones; Humans; Ligands; Luciferases; Male; Methylation; Mice; Mice, Nude; Prostate-Specific Antigen; Prostatic Neoplasms; Receptors, Androgen; Response Elements; Transcription, Genetic; Tumor Cells, Cultured | 2006 |
Suppressor of cytokine signaling-3 antagonizes cAMP effects on proliferation and apoptosis and is expressed in human prostate cancer.
Topics: Apoptosis; Cell Line, Tumor; Cell Proliferation; Cyclic AMP; Humans; Interleukin-3; Janus Kinases; Male; Methylation; Prostate; Prostatic Neoplasms; RNA, Small Interfering; Signal Transduction; STAT3 Transcription Factor; Suppressor of Cytokine Signaling 3 Protein; Suppressor of Cytokine Signaling Proteins; Transfection; Up-Regulation | 2006 |
Identification of a unique epigenetic sub-microenvironment in prostate cancer.
Topics: Base Sequence; CpG Islands; Epigenesis, Genetic; Epithelium; Glutathione S-Transferase pi; Humans; Male; Methylation; Microdissection; Promoter Regions, Genetic; Prostatic Hyperplasia; Prostatic Neoplasms; Stromal Cells | 2007 |
Safingol toxicology after oral administration to TRAMP mice: demonstration of safingol uptake and metabolism by N-acylation and N-methylation.
Topics: Acylation; Adenocarcinoma; Administration, Oral; Animals; Antineoplastic Agents; BALB 3T3 Cells; Biotransformation; Body Weight; Cell Line, Tumor; Cell Survival; Chemical and Drug Induced Liver Injury; Chromatography, High Pressure Liquid; Disease Models, Animal; Dose-Response Relationship, Drug; Hematocrit; Humans; Kidney Diseases; Liver; Liver Diseases; Male; Methylation; Mice; Mice, Transgenic; Prostatic Intraepithelial Neoplasia; Prostatic Neoplasms; Spectrometry, Mass, Electrospray Ionization; Sphingosine; Tissue Distribution | 2007 |
Small interfering RNA directed reversal of urokinase plasminogen activator demethylation inhibits prostate tumor growth and metastasis.
Topics: Animals; Coculture Techniques; Epigenesis, Genetic; Humans; Lung Neoplasms; Male; Methylation; Mice; Mice, Nude; Neoplasm Metastasis; Neoplasm Transplantation; Neovascularization, Pathologic; Prostatic Neoplasms; RNA, Small Interfering; Urokinase-Type Plasminogen Activator | 2007 |
[Detection of hypermethylated gene promotors in diagnosis of prostate cancer].
Topics: Adenocarcinoma; Biopsy; Glutathione S-Transferase pi; Humans; Male; Methylation; Prognosis; Promoter Regions, Genetic; Prostate; Prostatic Neoplasms | 2007 |
Rationale and clinical implication of combined chemotherapy with cisplatin and oestrogen in prostate cancer: primary evidence based on methylation analysis of oestrogen receptor-alpha.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Blotting, Western; Cisplatin; Estrogen Receptor alpha; Estrogens; Humans; Male; Methylation; Polymerase Chain Reaction; Prostatic Neoplasms; Sensitivity and Specificity; Tumor Cells, Cultured | 2008 |
JMJD3 is a histone H3K27 demethylase.
Topics: Binding Sites; Blotting, Western; Databases, Factual; DNA-Binding Proteins; Glutathione Transferase; HeLa Cells; Histones; Humans; Immunohistochemistry; Jumonji Domain-Containing Histone Demethylases; Lysine; Male; Methylation; Mutation; Neoplasm Metastasis; Oxidoreductases, N-Demethylating; Prostatic Neoplasms; Recombinant Fusion Proteins; Transfection | 2007 |
JARID1B is a histone H3 lysine 4 demethylase up-regulated in prostate cancer.
Topics: Cell Line, Tumor; Computational Biology; Dioxygenases; DNA-Binding Proteins; Gene Expression; Histones; Humans; Jumonji Domain-Containing Histone Demethylases; Lysine; Male; Methylation; Nuclear Proteins; Phylogeny; Prostatic Neoplasms; Protein Structure, Tertiary; Repressor Proteins; Up-Regulation | 2007 |
Genistein mediated histone acetylation and demethylation activates tumor suppressor genes in prostate cancer cells.
Topics: Acetylation; Anticarcinogenic Agents; Antimetabolites, Antineoplastic; Azacitidine; Blotting, Western; Cell Line, Tumor; Chromatin Immunoprecipitation; Chromones; CpG Islands; Decitabine; Deubiquitinating Enzyme CYLD; Down-Regulation; Electrophoretic Mobility Shift Assay; Enzyme Inhibitors; Forkhead Box Protein O3; Forkhead Transcription Factors; Gene Expression Regulation; Gene Expression Regulation, Neoplastic; Genes, p53; Genes, Tumor Suppressor; Genistein; Histones; Humans; Hydroxamic Acids; Male; Methylation; Morpholines; NF-kappa B; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Phytoestrogens; Prostatic Neoplasms; Protein Kinase Inhibitors; PTEN Phosphohydrolase; Reverse Transcriptase Polymerase Chain Reaction; Sirtuin 1; Sirtuins; Tumor Suppressor Proteins; Up-Regulation | 2008 |
Multivariate analysis of urinary RNA catabolites in malignancies: cross-sectional and longitudinal studies.
Topics: Analysis of Variance; Autoanalysis; Breast Neoplasms; Female; Humans; Kidney Neoplasms; Longitudinal Studies; Lung Neoplasms; Lymphoma; Male; Methylation; Neoplasms; Prostatic Neoplasms; Ribonucleosides; RNA | 1983 |
Prostate cancer research: current concepts and controversies.
Topics: Antibodies, Monoclonal; Chromosome Aberrations; Diethylstilbestrol; DNA; Flow Cytometry; Gonadotropin-Releasing Hormone; Humans; Male; Methylation; Oncogenes; Prostatic Neoplasms | 1983 |
E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas.
Topics: Base Sequence; Breast Neoplasms; Cadherins; DNA; Female; Gene Expression Regulation, Neoplastic; Humans; Male; Methylation; Molecular Sequence Data; Prostatic Neoplasms; Tumor Cells, Cultured | 1995 |
Cytidine methylation of regulatory sequences near the pi-class glutathione S-transferase gene accompanies human prostatic carcinogenesis.
Topics: Carcinoma; Cytidine; DNA Topoisomerases, Type I; Gene Expression Regulation, Enzymologic; Glutathione Transferase; Humans; Male; Methylation; Prostate; Prostatic Neoplasms; Regulatory Sequences, Nucleic Acid; Restriction Mapping; RNA, Messenger | 1994 |
Genomic methylation patterns of the Dunning R-3327 prostate adenocarcinoma system.
Topics: Adenocarcinoma; Antineoplastic Agents; DNA, Neoplasm; Eflornithine; Humans; Male; Methylation; Prostate; Prostatic Neoplasms; Reference Values; Tretinoin; Tumor Cells, Cultured | 1996 |
Hypermethylation-associated inactivation indicates a tumor suppressor role for p15INK4B.
Topics: Adult; Breast Neoplasms; Carrier Proteins; Cell Cycle Proteins; Cell Line; Child; Chromosome Deletion; Chromosome Mapping; Chromosomes, Human, Pair 9; Colonic Neoplasms; Cyclin-Dependent Kinase Inhibitor p15; Cyclin-Dependent Kinase Inhibitor p16; Dinucleoside Phosphates; DNA; DNA, Neoplasm; Female; Genes, Tumor Suppressor; Glioma; Homozygote; Humans; Leukemia; Leukemia, Myeloid, Acute; Lung Neoplasms; Lymphocytes; Male; Methylation; Polymerase Chain Reaction; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prostatic Neoplasms; Reference Values; Restriction Mapping; Tumor Cells, Cultured; Tumor Suppressor Proteins | 1996 |
Structure and methylation-associated silencing of a gene within a homozygously deleted region of human chromosome band 8p22.
Topics: Adenocarcinoma; Amino Acid Sequence; Animals; Base Sequence; Caenorhabditis elegans; Chromosomes, Artificial, Yeast; Chromosomes, Human, Pair 8; Cloning, Molecular; CpG Islands; DNA, Complementary; Gene Expression Regulation, Neoplastic; Genes, Tumor Suppressor; Humans; Lymphatic Metastasis; Male; Methylation; Middle Aged; Molecular Sequence Data; Neoplasm Proteins; Organ Specificity; Prostatic Neoplasms; RNA, Messenger; RNA, Neoplasm; Saccharomyces cerevisiae; Sequence Alignment; Sequence Deletion; Sequence Homology, Amino Acid; Species Specificity; Tumor Cells, Cultured | 1996 |
Hypermethylation of chromosome 17P locus D17S5 in human prostate tissue.
Topics: Base Sequence; Chromosomes, Human, Pair 17; Humans; Male; Methylation; Molecular Sequence Data; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms | 1996 |
Methylation of the 5' CpG island of the endothelin B receptor gene is common in human prostate cancer.
Topics: Dinucleoside Phosphates; Humans; Male; Methylation; Prostatic Neoplasms; Receptor, Endothelin B; Receptors, Endothelin; Regulatory Sequences, Nucleic Acid; Tumor Cells, Cultured | 1997 |
Expression of estrogen receptor (ER)-alpha and ER-beta in normal and malignant prostatic epithelial cells: regulation by methylation and involvement in growth regulation.
Topics: Cell Culture Techniques; Cell Division; Cells, Cultured; Diethylstilbestrol; Dose-Response Relationship, Drug; Estradiol; Estrogen Antagonists; Estrogen Receptor alpha; Estrogen Receptor beta; Estrogens, Non-Steroidal; Fulvestrant; Humans; Male; Methylation; Oligonucleotides, Antisense; Prostate; Prostatic Neoplasms; Protein Biosynthesis; Proteins; Receptors, Androgen; Receptors, Estrogen; Receptors, Progesterone; Reverse Transcriptase Polymerase Chain Reaction; RNA; Signal Transduction; Tamoxifen; Trefoil Factor-1; Tumor Cells, Cultured; Tumor Suppressor Proteins | 2000 |
Methylation of the E-cadherin gene promoter correlates with progression of prostate cancer.
Topics: Cadherins; Humans; Immunohistochemistry; Male; Methylation; Polymerase Chain Reaction; Promoter Regions, Genetic; Prostatic Neoplasms; Tumor Cells, Cultured | 2001 |
GSTP1 CpG island hypermethylation is responsible for the absence of GSTP1 expression in human prostate cancer cells.
Topics: Alleles; Base Sequence; Blotting, Southern; Carcinogenicity Tests; Cell Division; CpG Islands; DNA, Neoplasm; Glutathione S-Transferase pi; Glutathione Transferase; Humans; Isoenzymes; Male; Methylation; Prostatic Neoplasms; Reference Values; Tumor Cells, Cultured | 2001 |
Methylation-specific PCR for detection of neoplastic DNA in biopsy washings.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Biomarkers, Tumor; Biopsy; DNA, Neoplasm; Glutathione S-Transferase pi; Glutathione Transferase; Humans; Isoenzymes; Male; Methylation; Middle Aged; Polymerase Chain Reaction; Promoter Regions, Genetic; Prostatic Hyperplasia; Prostatic Intraepithelial Neoplasia; Prostatic Neoplasms | 2002 |
Carbon-11-labeled methylated polyamine analogs: uptake in prostate and tumor in animal models.
Topics: Animals; Carbon Radioisotopes; Dogs; Male; Melanoma; Methylation; Mice; Neoplasm Transplantation; Neoplasms, Experimental; Polyamines; Prostatic Neoplasms; Putrescine; Radionuclide Imaging; Rats; Spermidine; Spermine; Tomography | 1977 |
Hypomethylation of DNA in pathological conditions of the human prostate.
Topics: 5-Methylcytosine; Adult; Aged; Aged, 80 and over; Cytosine; DNA; Humans; Male; Mathematics; Methylation; Prostatic Hyperplasia; Prostatic Neoplasms | 1987 |
Initiation of malignant transformation and the significance of changes in transfer RNA methylase enzymes.
Topics: Animals; Carcinogens; Cell Line; Cell Transformation, Neoplastic; Cricetinae; Culture Techniques; Female; Kidney; Kidney Neoplasms; Male; Methylation; Methyltransferases; Mice; Neoplasms; Ovarian Neoplasms; Ovary; Prostate; Prostatic Neoplasms; RNA, Transfer; Transferases | 1971 |